MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Interventions"

  • 2022 International Congress

    Learning to PERSEVERE: Efficacy and Feasibility of Peer Mentor Support and Caregiver Education in Lewy Body Dementia

    J. Fleisher, F. Akram, S. Hess, M. Levin, D. Dodson, G. Stebbins, M. Tosin, B. Ouyang, J. Chodosh (Chicago, USA)

    Objective: To examine the effects of peer mentoring on caregiving mastery, Lewy Body Dementia (LBD) knowledge, and dementia attitudes among LBD family caregivers. Background: Few…
  • 2022 International Congress

    A facilitated self-management toolkit for people with Parkinson’s disease: A feasibility study of ‘Live Well with Parkinson’s

    M. Armstrong, T. Rookes, A. Schrag, K. Walters (London, United Kingdom)

    Objective: To assess the feasibility and acceptability of a theory and evidence-based digital facilitated self-management toolkit for people with Parkinson’s: ‘Live Well with Parkinson’s’. Background:…
  • 2022 International Congress

    Telephone nursing care for Parkinson’s patients: one-year experience in a tertiary referral hospital in Italy

    C. Tedesco, M. Campagnolo, M. Carecchio, F. Pistonesi, V. Cianci, M. Garon, R. Biundo, V. Misenti, A. Baba, A. Antonini (Padua, Italy)

    Objective: To establish a telephone nursing service led by a Parkinson Disease Nurse Specialists (PDNS) and monitor the one-year experience in a tertiary referral Italian hospital (Movement…
  • 2022 International Congress

    Longitudinal Program to Prevent PD (LoPP-PD): Multimodal Risk Stratification Informs Personalized Intervention

    K. Niotis, K. Akiyoshi, R. Isaacson, S. Isaacson (New York, USA)

    Objective: Longitudinal evaluation of personalized intervention strategies informed by detailed clinical and laboratory biomarker analysis to reduce relative risk of Parkinson’s disease in first degree…
  • 2022 International Congress

    A Pilot Feasibility Study of Medium Chain Triglyceride Nutritional Ketosis and Parkinson’s Disease

    A. Choi, M. Delgado, K. Chen, S. Chung, A. Courville, S. Turner, S. Yang, K. Airaghi, I. Dustin, P. Mcgurrin, M. Hallett, D. Ehrlich (Sun City, USA)

    Objective: To determine if nutritional ketosis supplemented by medium chain triglycerides (MCT) over the course of 2-3 weeks is acceptable and feasible in patients with…
  • 2022 International Congress

    Exploratory delayed-start analysis of PASADENA evaluating the efficacy of prasinezumab on motor progression and motor complications in early-stage Parkinson’s disease

    G. Pagano, S. Zanigni, A. Monnet, K. Taylor, A. Hahn, T. Simuni, K. Marek, R. Postuma, N. Pavese, F. Stocchi, H. Svoboda, P. Fontoura, R. Doody, G. Kerchner, A. Bonni, T. Nikolcheva (Basel, Switzerland)

    Objective: To evaluate the effect of prasinezumab on motor progression and motor complications in early-stage Parkinson’s disease (PD) using an exploratory delayed-start analysis of Part…
  • 2022 International Congress

    Opicapone Improves Global Non-Motor Symptoms Burden in Parkinson´s Disease: An Open-label Prospective Study

    D. Santos García, G. Fernández Pajarín, J. Oropesa Ruíz, F. Escamilla Sevilla, R. Rahim Lopez, G. Muñoz Enríquez (A Coruña, Spain)

    Objective: The aim of this study was to analyze the effectiveness of opicapone on global non-motor symptoms (NMS) burden in Parkinson´s disease (PD). Background: Some…
  • 2022 International Congress

    Clinical and device-based predictors of improvement in motor experiences of daily living after a short-term multidisciplinary inpatient treatment: a cohort study

    R. Scherbaum, J. Oppermann, A. Moewius, V. Tschentscher, J. Geritz, J. Welzel, C. Hansen, R. Gold, W. Maetzler, L. Tönges (Bochum, Germany)

    Objective: To determine predictors of improvement in motor experiences of daily living (m-EDL) after a multidisciplinary inpatient ‘PD multimodal complex treatment’ (PD-MCT) and clarify the…
  • 2022 International Congress

    Optimizing patient-centric clinical outcome assessments for use in Parkinson’s disease clinical trials: Critical Path for Parkinson’s multistakeholder initiative

    R. Speck, D. Trundell, J. Cedarbaum, M. Campbell, P. Chin, S. Crawford, T. Dam, D. Dexter, A. Goldfine, K. Klapper, C. Kopil, S. Lee, K. Marek, H. Matthews, T. Mestre, T. Morel, M. Minchik, M. Müller, K. Schroeder, T. Simuni, G. Stebbins, C. Yan, ML. Zeissler, D. Stephenson (Tucson, USA)

    Objective: To advance patient-centric endpoints for use in early-stage Parkinson’s disease (PD) clinical trials. Background: Limitations with currently available patient-centric clinical outcome assessments (COAs) has…
  • 2022 International Congress

    Estimating the Meaningful Within-Patient Change Threshold for the MDS-UPDRS Part III

    S. Zanigni, D. Trundell, A. Monnet, N. Shariati, E. Moore, E. Davies, N. Pross, G. Pagano, T. Nikolcheva (Basel, Switzerland)

    Objective: To estimate the meaningful within-patient worsening threshold (MWPWT) of the Movement Disorders Society–Unified Parkinson’s Disease Rating Scale (MDS-UPDRS Part III in early-stage Parkinson's disease…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 26
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
    • VIT-D and Tics Movement Disorder
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley